导航
| 统计阶段 | 收益率 | 同类排名 |
|---|---|---|
| 今年以来 | 38.32% | 71/4773 |
| 近一周 | -0.19% | 963/5465 |
| 近一月 | -2.12% | 1480/5421 |
| 近一季 | -18.81% | 4817/5231 |
| 近半年 | 29.16% | 81/4920 |
| 近一年 | 56.60% | 56/4394 |
| 近两年 | 257.43% | 47/2954 |
| 近三年 | 246.45% | 7/2253 |
| 成立以来 | 96.34% | - |
| 年份 | 年收益 | 1季度 | 2季度 | 3季度 | 4季度 |
| 2026 | - - |
1.40% 1290/4961 |
80.95% 178/5312 |
- - |
- - |
| 2025 | 98.53% 24/4813 |
-2.78% 2983/3635 |
6.31% 465/4076 |
79.23% 3/4524 |
7.16% 314/4813 |
| 2024 | 24.06% 309/3463 |
0.48% 965/2808 |
9.44% 49/3014 |
9.85% 2661/3129 |
2.71% 905/3463 |
| 2023 | 15.88% 33/2656 |
24.20% 106/2280 |
8.23% 20/2385 |
-12.75% 2125/2515 |
-1.19% 299/2655 |
| 2022 | -37.27% 1750/2207 |
-27.81% 1803/1919 |
3.21% 1191/2016 |
-19.48% 1783/2113 |
4.56% 536/2208 |
| 2021 | 5.71% 537/1822 |
-16.38% 1195/1255 |
21.03% 139/1330 |
-10.11% 1210/1466 |
16.20% 54/1822 |
| 2020 | - - |
- - |
27.61% 127/1067 |
-5.91% 1116/1164 |
-1.79% 1114/1184 |
| 2019 | - - |
- - |
- - |
- - |
- - |
| 2018 | - - |
- - |
- - |
- - |
- - |
| 2017 | - - |
- - |
- - |
- - |
- - |
| 2016 | - - |
- - |
- - |
- - |
- - |
| 2015 | - - |
- - |
- - |
- - |
- - |
| 2014 | - - |
- - |
- - |
- - |
- - |
| 2013 | - - |
- - |
- - |
- - |
- - |
| 基金名称 | 最新净值 | 季增长率 |
| 港股医疗ETF | 1.4546 | 31.90% |
| 华富中证港股通创新药指数型发起式A | 1.1637 | 30.96% |
| 天弘恒生沪深港创新药精选50ETF发起联接A | 1.3128 | 30.52% |
| 中欧中证港股通创新药指数发起A | 1.6103 | 30.52% |
| 嘉实中证港股通创新药指数发起式C | 0.8566 | 30.50% |
| 中欧中证港股通创新药指数发起C | 1.4583 | 30.44% |
| 永赢中证港股通医疗主题ETF发起联接A | 0.8927 | 30.26% |
| 景顺长城中证港股通创新药ETF联接C | 1.4696 | 29.97% |
| 华夏中证港股通医疗主题ETF发起式联接A | 0.8736 | 29.94% |
| 华夏中证港股通医疗主题ETF发起式联接C | 0.8719 | 29.88% |
| 银华中证5G通信主题ETF VS. 长安沪深300非周期A(740101) |